ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,234.08
-0.79%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) Noticias

TNXP Tonix Pharmaceuticals Holding Corporation

0.17
0.01005 (6.28%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.01005 6.28% 0.17 18:50:13
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.16 0.1597 0.1703 0.1685 0.15995
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202407:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/4/202415:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/3/202408:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202407:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202407:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202407:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202407:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202407:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202407:05EDGAR2Form 8-K - Current report
11/3/202407:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/3/202408:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/3/202407:06EDGAR2Form 8-K - Current report
07/3/202407:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/3/202416:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202407:05EDGAR2Form 8-K - Current report
06/3/202407:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
05/3/202407:05EDGAR2Form 8-K - Current report
05/3/202407:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
29/2/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202407:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
28/2/202407:06EDGAR2Form 8-K - Current report
28/2/202407:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
27/2/202407:07EDGAR2Form 8-K - Current report
27/2/202407:00GLOBETonix Pharmaceuticals Announces Positive Results from..
23/2/202408:30GLOBENew to The Street Announces Line-up of its Corporate..
20/2/202407:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/2/202408:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
15/2/202416:02EDGAR2Form 8-K - Current report
14/2/202414:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202407:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/2/202407:05EDGAR2Form 8-K - Current report
13/2/202407:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/2/202407:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/2/202406:06EDGAR2Form 8-K - Current report
31/1/202406:05EDGAR2Form 8-K - Current report
31/1/202406:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/1/202406:00EDGAR2Form 8-K - Current report
29/1/202406:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
25/1/202415:08EDGAR2Form 8-K - Current report
25/1/202406:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
19/1/202415:31EDGAR2Form 8-K - Current report
11/1/202415:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/1/202406:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
08/1/202416:07EDGAR2Form 8-K - Current report
08/1/202415:33EDGAR2Form DEF 14A - Other definitive proxy statements
03/1/202415:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202406:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..

Su Consulta Reciente

NASDAQ
TNXP
Tonix Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados